The newly organized research project "MELLODDY" (Machine Learning Ledger Orchestration for Drug Discovery), involving ten large pharma companies and seven technology providers, is that kind of deals which can catalyze a transition of the pharmaceutical industry to a new level -- a "paradigm shift", as one might refer to it in terms of Thomas Kuhn's "The Structure of Scientific Revolutions". The project aims at developing a state-of-the-art platform for collaboration, based on Owkin's blockchain architecture technology, which would allow collective training of artificial intelligence (AI) algorithms using data from multiple direct pharmaceutical competitors, without exposing their internal know-hows and compromising their intellectual property -- for the collective benefit of everyone involved. While artificial intelligence (AI) already proved to be a groundbreaking thing in many industries (robotics, finance, surveillance, cyber security, self-driving cars to name just a few), drug discovery still seems like a hard case for machine learning practitioners. A major reason for that is the lack of quality data to train models properly. It might seem surprising, as pharmaceutical research generates enormous amounts of data daily.

A breakthrough discovery shows that pterodactyls could fly from birth, something no other species before or since has been able to do. And British scientists said that the revelation has a'profound impact' on our understanding of the reptiles. The common belief was the pterodactyls, like birds and bats, only took to the air once they were fully grown. A new study shows pterodactyls could fly from birth, something no other species before or since can do. The findings have a'profound impact' on our understanding of reptiles Pterodactyls used both their arms and legs to push themselves off the ground during take-off, in a manoeuvre known as the'quadrupedal launch'. They were almost as tall as a giraffe with wing spans of around 32ft (10 metres).

Differential privacy is the gold standard in data privacy, with applications in the public and private sectors. While differential privacy is a formal mathematical definition from the theoretical computer science literature, it is also understood by statisticians and data experts thanks to its hypothesis testing interpretation. This informally says that one cannot effectively test whether a specific individual has contributed her data by observing the output of a private mechanism---any test cannot have both high significance and high power. In this paper, we show that recently proposed relaxations of differential privacy based on R\'enyi divergence do not enjoy a similar interpretation. Specifically, we introduce the notion of $k$-generatedness for an arbitrary divergence, where the parameter $k$ captures the hypothesis testing complexity of the divergence. We show that the divergence used for differential privacy is 2-generated, and hence it satisfies the hypothesis testing interpretation. In contrast, R\'enyi divergence is only $\infty$-generated, and hence has no hypothesis testing interpretation. We also show sufficient conditions for general divergences to be $k$-generated.

Hypothetical Testing is an application of your statistical model to the questions from the real world. In the hypothetical testing, you first assume the result as an assumption. It is called the null hypothesis. After the assumption, you hold an experiment for testing this hypothesis. Then after based on the results of the experiment.

Hypothesis Testing, as such an important statistical technique applied widely in A/B testing for various business cases, has been relatively confusing to many people at the same time. This article aims to summarize the concept of a few key elements of hypothesis testing as well as how they impact the test results. The story starts from hypothesis. When we want to know any characteristics about a population like the form of distribution, the parameter of interest(mean, variance etc.), we make an assumption about it, which is called the hypothesis of population. Then we pull samples from population, and test whether the sample results make sense given the assumption. For example, your manager somehow knew that the mean of the click-through-rate per user from company's website across the user base is 0.06(mean of CTR of population), while you doubt that and believe the CTR should be higher.

"Scientific research has changed the world. Now it needs to change itself. There has been a growing concern about the validity of scientific findings. A multitude of journals, papers and reports have recognized the ever smaller number of replicable scientific studies. In 2016, one of the giants of scientific publishing, Nature, surveyed about 1,500 researchers across many different disciplines, asking for their stand on the status of reproducibility in their area of research. One of the many takeaways to the worrisome results of this survey is the following: 90% of the respondents agreed that there is a reproducibility crisis, and the overall top answer to boosting reproducibility was "better understanding of statistics". Indeed, many factors contributing to the explosion of irreproducible research stem from the neglect of the fact that statistics is no longer as static as it was in the first half of the 20th century, when statistical hypothesis testing came into prominence as a ...

Allen, associate professor of statistics, computer science and electrical and computer engineering at Rice and of pediatrics-neurology at Baylor College of Medicine, will address the topic in both a press briefing and a general session today at the 2019 Annual Meeting of the American Association for the Advancement of Science (AAAS). "The question is, 'Can we really trust the discoveries that are currently being made using machine-learning techniques applied to large data sets?'" "The answer in many situations is probably, 'Not without checking,' but work is underway on next-generation machine-learning systems that will assess the uncertainty and reproducibility of their predictions." Machine learning (ML) is a branch of statistics and computer science concerned with building computational systems that learn from data rather than following explicit instructions. Allen said much attention in the ML field has focused on developing predictive models that allow ML to make predictions about future data based on its understanding of data it has studied. "A lot of these techniques are designed to always make a prediction," she said.

Rice University statistician Genevera Allen says scientists must keep questioning the accuracy and reproducibility of scientific discoveries made by machine-learning techniques until researchers develop new computational systems that can critique themselves. Allen, associate professor of statistics, computer science and electrical and computer engineering at Rice and of pediatrics-neurology at Baylor College of Medicine, will address the topic in both a press briefing and a general session today at the 2019 Annual Meeting of the American Association for the Advancement of Science (AAAS). "The question is, 'Can we really trust the discoveries that are currently being made using machine-learning techniques applied to large data sets?'" "The answer in many situations is probably, 'Not without checking,' but work is underway on next-generation machine-learning systems that will assess the uncertainty and reproducibility of their predictions." Machine learning (ML) is a branch of statistics and computer science concerned with building computational systems that learn from data rather than following explicit instructions. Allen said much attention in the ML field has focused on developing predictive models that allow ML to make predictions about future data based on its understanding of data it has studied.

A survey of early work exploring how AI can be used in medicine, with somewhat more technical expositions than in the complementary volume Artificial Intelligence in Medicine."Each chapter is preceded by a brief introduction that outlines our view of its contribution to the field, the reason it was selected for inclusion in this volume, an overview of its content, and a discussion of how the work evolved after the article appeared and how it relates to other chapters in the book.

JANICE S. AIKINS Dr. Aikins received her Ph.D. in computer science from Stanford University in 1980. She is currently a research computer scientist at IBM's Palo Alto Scientific Center. She specializes in designing systems with an emphasis on the explicit representation of control knowledge in expert systems. ROBERT L. BLUM Dr. Blum received his M.D. from the University of California Medical School at San Francisco in 1973. From 1973 to 1976 he did an internship and residency in the Department of Internal Medicine at the Kaiser Foundation Hospital in Oakland, California, where he was chief resident in 1976.